EP2134313A2 - Cosmetic composition comprising a fine powder - Google Patents
Cosmetic composition comprising a fine powderInfo
- Publication number
- EP2134313A2 EP2134313A2 EP08788180A EP08788180A EP2134313A2 EP 2134313 A2 EP2134313 A2 EP 2134313A2 EP 08788180 A EP08788180 A EP 08788180A EP 08788180 A EP08788180 A EP 08788180A EP 2134313 A2 EP2134313 A2 EP 2134313A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- composition according
- copolymers
- composition
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 149
- 239000000843 powder Substances 0.000 title claims abstract description 92
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 239000012071 phase Substances 0.000 claims abstract description 62
- 239000008346 aqueous phase Substances 0.000 claims abstract description 37
- 239000000839 emulsion Substances 0.000 claims abstract description 14
- 239000007764 o/w emulsion Substances 0.000 claims abstract description 8
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 claims description 38
- 229920001577 copolymer Polymers 0.000 claims description 30
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- -1 aliphatic diamine Chemical class 0.000 claims description 22
- 239000002245 particle Substances 0.000 claims description 22
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 claims description 21
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 16
- 239000000178 monomer Substances 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 229920002292 Nylon 6 Polymers 0.000 claims description 13
- 150000003951 lactams Chemical class 0.000 claims description 13
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 12
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 230000003020 moisturizing effect Effects 0.000 claims description 11
- 229920005862 polyol Polymers 0.000 claims description 11
- 229920006659 PA12 Polymers 0.000 claims description 10
- YDLSUFFXJYEVHW-UHFFFAOYSA-N azonan-2-one Chemical compound O=C1CCCCCCCN1 YDLSUFFXJYEVHW-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 10
- 150000003077 polyols Chemical class 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 235000011037 adipic acid Nutrition 0.000 claims description 8
- 239000001361 adipic acid Substances 0.000 claims description 8
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 8
- 239000002562 thickening agent Substances 0.000 claims description 8
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 102000011782 Keratins Human genes 0.000 claims description 5
- 108010076876 Keratins Proteins 0.000 claims description 5
- 239000004909 Moisturizer Substances 0.000 claims description 5
- 239000013543 active substance Substances 0.000 claims description 5
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- GUOSQNAUYHMCRU-UHFFFAOYSA-N 11-Aminoundecanoic acid Chemical compound NCCCCCCCCCCC(O)=O GUOSQNAUYHMCRU-UHFFFAOYSA-N 0.000 claims description 4
- JZUHIOJYCPIVLQ-UHFFFAOYSA-N 2-methylpentane-1,5-diamine Chemical compound NCC(C)CCCN JZUHIOJYCPIVLQ-UHFFFAOYSA-N 0.000 claims description 4
- RNLHGQLZWXBQNY-UHFFFAOYSA-N 3-(aminomethyl)-3,5,5-trimethylcyclohexan-1-amine Chemical compound CC1(C)CC(N)CC(C)(CN)C1 RNLHGQLZWXBQNY-UHFFFAOYSA-N 0.000 claims description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims description 4
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 claims description 4
- 229920000572 Nylon 6/12 Polymers 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000004985 diamines Chemical class 0.000 claims description 4
- TVIDDXQYHWJXFK-UHFFFAOYSA-N dodecanedioic acid Chemical compound OC(=O)CCCCCCCCCCC(O)=O TVIDDXQYHWJXFK-UHFFFAOYSA-N 0.000 claims description 4
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 claims description 4
- 150000002596 lactones Chemical class 0.000 claims description 4
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 claims description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000516 sunscreening agent Substances 0.000 claims description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 4
- HASUJDLTAYUWCO-UHFFFAOYSA-N 2-aminoundecanoic acid Chemical compound CCCCCCCCCC(N)C(O)=O HASUJDLTAYUWCO-UHFFFAOYSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 230000002051 biphasic effect Effects 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 230000001815 facial effect Effects 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 claims description 2
- SPJXZYLLLWOSLQ-UHFFFAOYSA-N 1-[(1-aminocyclohexyl)methyl]cyclohexan-1-amine Chemical compound C1CCCCC1(N)CC1(N)CCCCC1 SPJXZYLLLWOSLQ-UHFFFAOYSA-N 0.000 claims description 2
- PBLZLIFKVPJDCO-UHFFFAOYSA-N 12-aminododecanoic acid Chemical compound NCCCCCCCCCCCC(O)=O PBLZLIFKVPJDCO-UHFFFAOYSA-N 0.000 claims description 2
- YZTJKOLMWJNVFH-UHFFFAOYSA-N 2-sulfobenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1S(O)(=O)=O YZTJKOLMWJNVFH-UHFFFAOYSA-N 0.000 claims description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims description 2
- XDOLZJYETYVRKV-UHFFFAOYSA-N 7-Aminoheptanoic acid Chemical compound NCCCCCCC(O)=O XDOLZJYETYVRKV-UHFFFAOYSA-N 0.000 claims description 2
- 229960002684 aminocaproic acid Drugs 0.000 claims description 2
- CJYXCQLOZNIMFP-UHFFFAOYSA-N azocan-2-one Chemical compound O=C1CCCCCCN1 CJYXCQLOZNIMFP-UHFFFAOYSA-N 0.000 claims description 2
- 229930188620 butyrolactone Natural products 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 239000007859 condensation product Substances 0.000 claims description 2
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000539 dimer Substances 0.000 claims description 2
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- XTBMQKZEIICCCS-UHFFFAOYSA-N hexane-1,5-diamine Chemical compound CC(N)CCCCN XTBMQKZEIICCCS-UHFFFAOYSA-N 0.000 claims description 2
- 229910003002 lithium salt Inorganic materials 0.000 claims description 2
- 159000000002 lithium salts Chemical class 0.000 claims description 2
- ZETYUTMSJWMKNQ-UHFFFAOYSA-N n,n',n'-trimethylhexane-1,6-diamine Chemical compound CNCCCCCCN(C)C ZETYUTMSJWMKNQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960005137 succinic acid Drugs 0.000 claims description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 claims 2
- JCUZDQXWVYNXHD-UHFFFAOYSA-N 2,2,4-trimethylhexane-1,6-diamine Chemical compound NCCC(C)CC(C)(C)CN JCUZDQXWVYNXHD-UHFFFAOYSA-N 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 230000000379 polymerizing effect Effects 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 18
- 239000007788 liquid Substances 0.000 abstract description 15
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 235000019197 fats Nutrition 0.000 description 15
- 238000003756 stirring Methods 0.000 description 11
- 241000761389 Copa Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 229920002545 silicone oil Polymers 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 206010040954 Skin wrinkling Diseases 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000004952 Polyamide Substances 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 229920006017 homo-polyamide Polymers 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 229920002647 polyamide Polymers 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 150000002513 isocyanates Chemical class 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 3
- 229920000299 Nylon 12 Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- 239000004953 Aliphatic polyamide Substances 0.000 description 2
- 108020005224 Arylamine N-acetyltransferase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229920003231 aliphatic polyamide Polymers 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000346 nonvolatile oil Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- OXDXXMDEEFOVHR-CLFAGFIQSA-N (z)-n-[2-[[(z)-octadec-9-enoyl]amino]ethyl]octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)NCCNC(=O)CCCCCCC\C=C/CCCCCCCC OXDXXMDEEFOVHR-CLFAGFIQSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- QWDQYHPOSSHSAW-UHFFFAOYSA-N 1-isocyanatooctadecane Chemical compound CCCCCCCCCCCCCCCCCCN=C=O QWDQYHPOSSHSAW-UHFFFAOYSA-N 0.000 description 1
- DVPHDWQFZRBFND-DMHDVGBCSA-N 1-o-[2-[(3ar,5r,6s,6ar)-2,2-dimethyl-6-prop-2-enoyloxy-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]-2-[4-[(2s,3r)-1-butan-2-ylsulfanyl-2-(2-chlorophenyl)-4-oxoazetidin-3-yl]oxy-4-oxobutanoyl]oxyethyl] 4-o-[(2s,3r)-1-butan-2-ylsulfanyl-2-(2-chloropheny Chemical group C1([C@H]2[C@H](C(N2SC(C)CC)=O)OC(=O)CCC(=O)OC(COC(=O)CCC(=O)O[C@@H]2[C@@H](N(C2=O)SC(C)CC)C=2C(=CC=CC=2)Cl)[C@@H]2[C@@H]([C@H]3OC(C)(C)O[C@H]3O2)OC(=O)C=C)=CC=CC=C1Cl DVPHDWQFZRBFND-DMHDVGBCSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KMUBFTBPGVULKC-UHFFFAOYSA-N 2-hexyldecyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC KMUBFTBPGVULKC-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- ZIIVEKCKOPDBLT-UHFFFAOYSA-N 2-octyldodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)O)CCCCCCCC ZIIVEKCKOPDBLT-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- IGSBHTZEJMPDSZ-UHFFFAOYSA-N 4-[(4-amino-3-methylcyclohexyl)methyl]-2-methylcyclohexan-1-amine Chemical compound C1CC(N)C(C)CC1CC1CC(C)C(N)CC1 IGSBHTZEJMPDSZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- PCUXMDACXTVDGR-UHFFFAOYSA-N 4-methylpentyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCOC(=O)C(C)(C)C PCUXMDACXTVDGR-UHFFFAOYSA-N 0.000 description 1
- LHWUVOILCRBENG-UHFFFAOYSA-N 7-methyloctyl 7-methyloctanoate Chemical compound CC(C)CCCCCCOC(=O)CCCCCC(C)C LHWUVOILCRBENG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000009967 Erodium cicutarium Nutrition 0.000 description 1
- UAUDZVJPLUQNMU-UHFFFAOYSA-N Erucasaeureamid Natural products CCCCCCCCC=CCCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 101000884385 Homo sapiens Arylamine N-acetyltransferase 1 Proteins 0.000 description 1
- 101001034811 Homo sapiens Eukaryotic translation initiation factor 4 gamma 2 Proteins 0.000 description 1
- 101000639975 Homo sapiens Sodium-dependent noradrenaline transporter Proteins 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229920007813 Orgasol® 2001 UD NAT 1 Polymers 0.000 description 1
- 229920013588 Orgasol® 3502 D NAT 1 Polymers 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 102100033769 Sodium-coupled neutral amino acid transporter 3 Human genes 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 229910010413 TiO 2 Inorganic materials 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- PDWFFEHBPAYQGO-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-hexyl-dimethylsilane Chemical compound CCCCCC[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C PDWFFEHBPAYQGO-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000011952 anionic catalyst Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N cis-oleyl alcohol Natural products CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- DDJSWKLBKSLAAZ-UHFFFAOYSA-N cyclotetrasiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]1 DDJSWKLBKSLAAZ-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- UAXZKOFYXXDTFH-UHFFFAOYSA-N n-[2-(hexadecanoylamino)ethyl]hexadecanamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCNC(=O)CCCCCCCCCCCCCCC UAXZKOFYXXDTFH-UHFFFAOYSA-N 0.000 description 1
- RKISUIUJZGSLEV-UHFFFAOYSA-N n-[2-(octadecanoylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCNC(=O)CCCCCCCCCCCCCCCCC RKISUIUJZGSLEV-UHFFFAOYSA-N 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229920006012 semi-aromatic polyamide Polymers 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- GBXQPDCOMJJCMJ-UHFFFAOYSA-M trimethyl-[6-(trimethylazaniumyl)hexyl]azanium;bromide Chemical compound [Br-].C[N+](C)(C)CCCCCC[N+](C)(C)C GBXQPDCOMJJCMJ-UHFFFAOYSA-M 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
Definitions
- the present invention relates to cosmetic compositions used in the field of care and makeup.
- This composition mainly comprising a continuous aqueous phase, a fat phase and a pulverulent phase of copolyamide powder, which is fine and porous, is in the form of creamy, liquid, gelled compositions. It is in particular an emulsion, but it can also be a biphasic formulation or composition in which the fatty and aqueous phases are separated.
- the invention relates more particularly to cosmetic compositions for care and / or makeup having a continuous aqueous phase in the case of an oil-in-water emulsion.
- surfactants thickeners, and more generally surfactants
- additives such as preservatives and perfumes, but also cosmetic active agents such as moisturizers (polyols), anti-UV agents, anti-wrinkles, self-tanners, film-forming agents and antioxidants. many others.
- the invention also relates to a process for the makeup and / or care of keratin materials such as the skin, the lips, the nails, the hair, the eyelashes, the eyebrows, the hairs of a human being, including the application of the composition according to the invention on keratin materials.
- the composition according to the invention may be a make-up and / or skincare composition for keratinous substances, in particular a facial care composition (such as, for example, a moisturizing cream or fluid, anti-wrinkle, and / or or makeup remover ..., but also a two-phase moisturizing and / or make-up removing lotion), a body care composition (such as a moisturizing, slimming composition), a water-resistant sunscreen composition ("waterproof" "In English terminology) or non-water resistant, a makeup composition of the skin, such as a foundation, an eyeshadow, a mascaras, a blusher, a concealer, a product body makeup.
- a facial care composition such as, for example, a moisturizing cream or fluid, anti-wrinkle, and / or makeup remover ..., but also a two-phase moisturizing and / or make-up removing lotion
- a body care composition such as a moisturizing, slimming composition
- a water-resistant sunscreen composition (“
- compositions of the continuous aqueous phase type have numerous cosmetic and galenical advantages. They are particularly inexpensive and comfortable to use since they do not have a greasy feel. However, their disadvantage is that they have a consistency too close to the consistency of water to be attractive to consumers and present difficulties in the application. In addition, after the disappearance of the feeling of moisture on the skin, they do not improve comfort, care or the visual appearance of the skin (no powdery appearance for example).
- a cosmetic composition comprising a liquid base, cream or powder, a perfume and a powder formed of spherical, cylindrical or dumbbell-shaped polyamide particles (abbreviated PA). These particles are porous, have an average diameter of 1 to 30 ⁇ m, a specific surface area of 5 m 2 / g or more, an absorption of linseed oil of 200 ml / 100 g or more, a crystallinity of 40% or more and a ratio of the average volume diameter to the number average diameter of 1.0 to 1.5.
- PA spherical, cylindrical or dumbbell-shaped polyamide particles
- the homopolyamide powder 12 or 6 of these compositions causes a light-diffusing effect on the surface of the skin and has a high absorption capacity of the sebum, which effectively reduces the abnormal reflection of the light produced on the skin. skin at the time of application of said compositions on the skin.
- the polyamide powders described in this prior art do not solve the problems encountered for compositions in a continuous aqueous phase: in fact, the homopolyamide powders 6, if they they increase the consistency of the formulations in a continuous aqueous phase, giving the user the feeling of richness that he expects at the time of application, they do not lead, after the application of the formulation, to a soft touch.
- homopolyamide 12 powders have practically no effect on the consistency of continuous aqueous phase formulations. These retain, despite the addition of polyamide powder, the consistency of water very little appreciated by users. On the other hand, the touch left on the skin after application is very soft.
- copolyamide powders it was possible to prepare compositions in continuous aqueous phases imparting a feeling of richness to said composition, expected by the users, and leaving, after application, a soft powdery touch.
- the subject of the invention is a composition which comprises (i) an aqueous phase, (ii) a fatty phase and (iii) a pulverulent phase comprising a copolyamide powder resulting from the polymerization of at least two different monomers described below and optionally other compounds defined below.
- This composition may be a continuous aqueous phase emulsion (oil in water) or a biphasic composition with a separate aqueous phase and a fatty phase.
- the continuous aqueous phase according to the invention may comprise thickeners, emollients, humectants (such as polyols) and / or moisturizers.
- the fatty phase according to the invention may comprise solid or liquid fatty substances of plant, mineral, animal or synthetic origin.
- esters for example, esters, fatty alcohols, fatty acids, hydrocarbons essentially comprising carbon and hydrogen atoms and possibly nitrogen and oxygen atoms. Mention may also be made of silicone oils and fluorinated oils.
- the composition is characterized in that the powder particles have a mean diameter ranging from 1 ⁇ m to 200 ⁇ m, preferably from 1 to 100 ⁇ m, even more preferably from 1 to 50 ⁇ m, even more advantageously from 1 ⁇ m to 1 ⁇ m. at 20 ⁇ m, a specific surface area of between 1 and 25 m 2 / g and a spheroidal shape.
- the composition is characterized in that it comprises (% by weight relative to the total composition):
- the composition is characterized in that the aqueous phase comprises from 1 to 99% (% by weight relative to the total composition) of polyols, preferably from 10 to 60%.
- the composition is characterized in that it comprises at least one cosmetic ingredient chosen from antioxidants, perfumes, preservatives, neutralizers, surfactants, film-forming polymers, thickeners, radiation blockers ultra violet, vitamins, dyestuffs, emulsion stabilizers, moisturizers, self-tanning compounds, anti-wrinkle active agents and mixtures thereof.
- at least one cosmetic ingredient chosen from antioxidants, perfumes, preservatives, neutralizers, surfactants, film-forming polymers, thickeners, radiation blockers ultra violet, vitamins, dyestuffs, emulsion stabilizers, moisturizers, self-tanning compounds, anti-wrinkle active agents and mixtures thereof.
- the composition is characterized in that it is a moisturizing, anti-wrinkle and / or makeup-removing facial cream or fluid, a cream or a moisturizing and / or slimming body care fluid, a cream water resistant or non-water resistant, foundation, eye shadow, mascara, blush, concealer or body make-up product, two-phase lotion, moisturizing or make-up remover.
- the invention also relates to the use of a composition for producing a make-up and / or skin care product conferring on the skin giving the skin a soft touch and a matte, powdery appearance after application to said skin. skin.
- the invention also relates to a cosmetic process for the makeup and / or care of keratin materials, comprising the application to these materials of a composition as described above.
- the use of the fine and porous powder is characterized in that the powder particles have a mean diameter ranging from 5 to 20 ⁇ m.
- the use of the fine and porous powder is characterized in that the powder particles have a spheroidal shape.
- copolyamide powder (abbreviated CoPA powder), it is meant the condensation products of at least two different monomers chosen from:
- lactams By way of example of lactams, mention may be made of those having from 3 to 12 carbon atoms on the main ring and which may be substituted. Examples that may be mentioned include ⁇ , ⁇ -dimethylpropriolactam, ⁇ , ⁇ -dimethylpropriolactam, amylolactam, caprolactam, capryllactam, oenantholactam, 2-pyrrolidone and lauryllactam.
- a dicarboxylic acid there may be mentioned acids having between 4 and 18 carbon atoms of carbon. Mention may be made, for example, of adipic acid, sebacic acid, azelaic acid, suberic acid, isophthalic acid, butanedioic acid, 1,4-cyclohexyldicarboxylic acid, terephthalic acid, sodium or lithium salt of sulphoisophthalic acid, dimerized fatty acids (these dimerized fatty acids have a dimer content of at least 98% and are preferably hydrogenated) and dodecanedioic acid HOOC- (CH2) io ⁇ COOH.
- adipic acid sebacic acid, azelaic acid, suberic acid
- isophthalic acid butanedioic acid
- 1,4-cyclohexyldicarboxylic acid 1,4-cyclohexyldicarboxylic acid
- terephthalic acid sodium or lithium salt of sul
- a diamine it can be an aliphatic diamine having from 6 to 12 atoms, it can be arylic and / or saturated cyclic.
- MPDM methyl pentamethylenediamine
- AMF bis (aminocyclohexyl) methane
- BMACM bis (3-methyl-4-aminocyclohexyl) methane
- methaxylyenediamine bis-p-aminocyclohexylmethane and trimethylhexamethylenediamine.
- the method consists in suspending the lactam in an organic liquid or in a solution in a solvent and in carrying out an anionic polymerization which makes it possible to directly obtain CoPA powder which separates itself from the liquid medium as it is formed.
- the method of anionic polymerization of lactams is based essentially on the use of a catalyst such as sodium or one of its compounds such as sodium hydride or sodium methoxide and an activator such as lactam-N- carboxyanilides, isocyanates, carbodi-imides, cyanimides, acyl-lactams, triazines, ureas, imides-N-substituted and esters, among others, optionally in the presence of a finely divided mineral or organic filler having a role of crystallization nucleus such as PA powder (for example ORGASOL® powder), silica, talc and in the presence of an N, N'-alkylenebisamide, more particularly N, N'ethylene bis stearamide, N, N'-ethylene bis oleamide, N, N'-ethylene bis palmitamide, gadoleamide, cetoleamide and erucamide, N, N'-dioleyldipamide and N, N'diéruc
- Copolyamides resulting from the condensation of at least two alpha omega aminocarboxylic acids or two lactams or a lactam and an alpha omega aminocarboxylic acid may be mentioned.
- alpha-omega amino acids there may be mentioned aminocaproic acid, amino-7-heptanoic acid, amino-11-undecanoic acid and amino-12-dodecanoic acid.
- copolyamides resulting from the condensation of an aliphatic diamine with an aliphatic dicarboxylic acid and at least one other monomer chosen from aliphatic diamines different from the preceding one and the aliphatic diacids different from the preceding one.
- copolyamides By way of examples of copolyamides, mention may be made of copolymers of caprolactam and lauryl lactam (PA 6/12), copolymers of caprolactam, adipic acid and hexamethylenediamine (PA 6 / 6-6), copolymers of caprolactam, lauryl lactam, adipic acid and hexamethylenediamine (PA 6/12 / 6-6), copolymers of caprolactam, lauryl lactam, amino undecanoic acid, azelaic acid and hexamethylenediamine (PA 6 / 6-9 / 1 1/12), copolymers of caprolactam, lauryl lactam, 1-undecanoic amino acid, adipic acid and hexamethylenediamine (PA 6 / 6-6) 1/1), copolymers of lauryl lactam, azelaic acid and hexamethylenediamine (PA 6-9 / 12), copoly
- Polyamide and / or copolyamide can be used. These are, for example, mixtures of aliphatic polyamides and semi-aromatic polyamides and mixtures of aliphatic polyamides and cycloaliphatic polyamides.
- the powders can be made by any means, dissolved and precipitated in an alcohol.
- polymerization is produced in a solvent, the powders being insoluble in this solvent (anionic polymerization defined above).
- anionic polymerization defined above.
- copolyesteramide powders resulting from the condensation of (the total being 100%):
- lactams that can be used to make the copolyesteramides are the same as those mentioned above.
- Caprolactam and lauryllactam are advantageously used.
- lactones there may be mentioned caprolactone, valerolactone and butyrolactone.
- Caprolactone is advantageously used.
- caprolactam, lauryllactam and caprolactone are advantageously used in the following proportions (mol%): 30-46%, 30-46% and 8-40% (the total being 100% ).
- a fatty phase may contain a liquid fatty phase and possibly a solid fatty phase (such as waxes).
- the liquid fatty phase may contain one or more liquid oils at room temperature (25 ° C), these oils are volatile or not.
- the liquid fatty phase is formed of hydrocarbon oils or possibly of silicone oils.
- the fatty phase comprises one or more oils, that is, immiscible fatty substances with water.
- oils that is, immiscible fatty substances with water.
- These volatile or non-volatile oils are of mineral, animal, vegetable or synthetic origin and may be hydrocarbon, silicone or fluorinated.
- hydrocarbon-based oil means an oil formed essentially or even consisting of carbon and hydrogen atoms and optionally oxygen and nitrogen atoms. It may contain alcohol, ester, ether, carboxylic acid, amine and / or amide groups.
- nonvolatile liquid oil means an oil capable of remaining on the skin at ambient temperature (25 ° C.) and atmospheric pressure for at least one hour and having in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure, non-zero, less than or equal to 0.01 mmHg (1.33 Pa).
- the liquid fatty phase advantageously comprises one or more non-volatile oils which provide an emollient effect on the skin.
- Fatty esters such as cetearyl isononoate, isostearyl isotridecyl isostearate isononoate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, isononyl isononate, 2-ethylhexyl palmitate, 2-hexyldecyl laurate, 2-octyl decyl palmitate, myristate or 2-octyldodecyl lactate, succinate 2 diethyl hexyl, diisostearyl malate, triisostearate of glycerine or triglycerine, tocopherol acetate, higher fatty acids such as myristic acid, palmitic acid, stearic acid,
- the composition comprises non-volatile silicone oils such as dimethylsiloxanes.
- the liquid fatty phase may also optionally comprise volatile oils.
- volatile oil is meant an oil capable of evaporating from the skin in less than one hour at room temperature and atmospheric pressure. This oil has in particular a vapor pressure at ambient temperature (25 ° C.) and atmospheric pressure (760 mmHg) greater than 0.01 and less than or equal to 300 mmHg (1.33 Pa to 40 000 Pa) and preferably ranging from 0.05 to 300 mmHg (6.65 Pa to 40,000 Pa).
- the volatile oils are for example chosen from silicone oils which contribute to reducing the fat effect of continuous fat phase formulations. Mention may be made of linear or cyclic silicone oils having a viscosity at room temperature of less than 8 mm 2 / s and in particular having from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups having from 1 to 10 carbon atoms. carbon.
- volatile silicone oil that may be used in the invention, there may be mentioned in particular actamethyl cyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyltrisiloxane, heptamethyl octyltrisiloxane, hexamethyl disiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, dodecamethylpentasiloxane and mixtures thereof.
- cyclomethicone DC 345 from Dow Corning
- caprylyl methicone DC245 from Dow Corning
- the aqueous phase contains water.
- the latter may be a floral water such as cornflower water and / or mineral water such as VITTEL water, LUCAS water, LA ROCHE POSAY water and / or thermal water.
- the aqueous phase may also comprise constituents which are miscible with water, for example primary alcohols such as ethanol and isopropanol, polyols such as glycols added for their humectant properties: glycerol, propylene glycol and butylene. glycol, dipropylene glycol, diethylene glycol, glycol ethers such as mono-, di- or tripropylene glycol (C1-C4) alkyl ethers, mono, di or triethylene glycol and mixtures thereof.
- primary alcohols such as ethanol and isopropanol
- polyols such as glycols added for their humectant properties: glycerol, propylene glycol and butylene.
- the aqueous phase may further comprise stabilizing agents such as sodium chloride, magnesium dichloride and magnesium sulfate.
- the aqueous phase may also comprise any water-soluble or water-dispersible compounds compatible with an aqueous phase such as gelling agents, film-forming polymers, thickeners, surfactants and their mixture.
- the cosmetic composition according to the invention may also comprise surfactants (generally lipophilic) of anionic, nonionic or amphoteric type facilitating the dispersion of the fatty phase in the aqueous phase so as to obtain a stable oil / water emulsion, additives such as preservatives (generally hydrophilic), perfumes (generally lipophilic), different fillers of the powder according to the invention, dyestuffs (soluble dyes, pigments), thickeners (waxes, gelling agents), emulsion stabilizers (usually hydrophilic), chelators (usually hydrophilic).
- surfactants generally lipophilic
- anionic, nonionic or amphoteric type facilitating the dispersion of the fatty phase in the aqueous phase so as to obtain a stable oil / water emulsion
- additives such as preservatives (generally hydrophilic), perfumes (generally lipophilic)
- different fillers of the powder according to the invention dyestuffs (soluble dyes, pigment
- the surfactants may be of ester type such as sorbitan derivatives (ex sorbitan sesquiisostearate), methyl glucose isostearate. They can be of polymeric types such as PEG-45 / dodecylglycol copolymer. They may also be silicone surfactants suitable for the emulsification of silicone oils: it is for example dimethicone copolyols such as PEG / PPG-18/18 dimethicone marketed by Dow Corning under the name DC5225C.
- the thickeners may for example be soluble in the fatty phase to adjust its consistency or contribute to the stability of the composition: example candellila wax, gums or silicone elastomers (DC141 1 and DC9040 from Dow Corning).
- Preservatives are mixtures of derivatives of paraben and / or phenoxyethanol.
- EDTA ethylene diamine tetraAcetic
- the cosmetic active agents may also comprise cosmetic active agents that provide an improvement in the human keratin materials mentioned above.
- the cosmetic active agents include moisturizers (generally hydrophilic) such as polyols, UV radiation blockers such as organic filters (generally lipophilic) or mineral particles such as TiO2, ZnO surface-treated or non-surface treated, anti-wrinkles (generally hydrophilic) , self-tanners (generally hydrophilic), film-forming agents (lipophilic or hydrophilic depending on their nature), antioxidants (lipophilic or hydrophilic depending on their nature).
- dispersions of ZnO and TiO 2 may be mentioned in silicone oil mixtures.
- the aqueous phase preferably comprises 1 to 99% by weight of polyols relative to the total aqueous phase, preferably 10 to 60%.
- it may comprise 0.5 to 10%, preferably 3 to 5% of surfactants, 0.01 to 2% of additives, 0.005 to 10% of cosmetic active ingredients relative to the total composition.
- the characteristics of the CoPA powders of the composition, object of the invention are:
- the mean diameter of the particles is from 0.1 to 100 ⁇ m, preferably from 0.5 to 50 ⁇ m, even more advantageously from 1 to 20 ⁇ m.
- the particle size distribution of the powders is determined according to the usual techniques, for example using a Coulter Multisizer II granulometer according to the ISO 13319 standard. From the particle size distribution, it is possible to determine the mean diameter as well as the particle size dispersion. (standard deviation) which measures the tightening of the distribution. This is one of the advantages of the described method that allow obtain a narrow distribution with a standard deviation of between 1 and 3 ⁇ m, or often less than 2 ⁇ m;
- the shape of the particles advantageously spheroidal, that is to say in the form of spheroid which means: solid approximately spherical.
- the characteristics listed above contribute greatly to the soft touch in the continuous aqueous phase systems and to obtaining after application of the matt and powdered appearance of the composition.
- Powder 1 Orgasol®2002EXD NAT COS, ie PA12 powder, average particle diameter 10 ⁇ m, SSA 4 +/- 1, 5 m 2 / g, flax oil content of 79 g / 100 g, obtained according to the process described in EP192515.
- Powder 2 ORGASOL® seeded PA12 / PA6 copolyamide powder, 80/20 particle size 10 ⁇ m, SSA 9.5 +/- 1 m 2 / g ,.
- 2800 ml of solvent are introduced into the reactor maintained under nitrogen, followed successively by 108 g of caprolactam, 679 g of dry lauryl lactam, 14.4 g of EBS and 1 12 g of ORGASOL® 2001 UD NAT1 finely divided. After stirring at 300 rpm, the mixture is gradually heated to 110 ° C. and 290 ml of solvent are then distilled off under vacuum in order to azeotrope traces of water that may be present.
- the anionic catalyst 7.2 g of sodium hydride at 60% purity in oil, are rapidly introduced under nitrogen and the stirring is increased to 720 r / min under nitrogen at 110 ° C for 30 minutes.
- the temperature is brought to 96 ° C. and, thanks to a small dosing pump, a continuous injection into the reaction medium of the chosen activator, namely stearyl isocyanate (32.9 g filled to 314 g with solvent), according to the following schedule:
- the reactor is almost clean.
- the particle size of between 2 and 20 microns with the average particle diameter being 11, 8 microns and a SSA 9.3 m2 / g without agglomerate.
- Powder 3 Orgasol®3502 D NAT1 copolyamide powder PA12 / PA6 (50/50), average particle diameter 20 ⁇ m, SSA 2.5 +/- 1 m 2 / g.
- Powder 4 copolyamide powder PA12 / PA6 (50/50), average particle diameter
- Powder 5 Orqasol®3202D NAT1 copolyamide powder PA12 / PA6 (20/80), average particle diameter 20 ⁇ m, SSA 1 +/- 1 m 2 / g.
- Powder 6 Orgasol® 1002 D NAT COS, polyamide 6 powder, average particle diameter 20 ⁇ m, SSA 1 +/- 1 m 2 / g.
- composition VOOIN does not include powder.
- compositions comprising the Powders 1 to 6 are defined below for each table.
- composition is analyzed blind by comparison of all the tests forming a series.
- compositions A to F and Control 1 are oil-in-water type emulsion compositions comprising 5% fat phase corresponding, for example, to light cream compositions.
- the process for preparing the compositions below consists in (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously so as to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with gentle stirring .
- Composition A: x 3.5% of powder 1.
- Composition B: x 3.5% of powder 2.
- Composition C: x 3.5% of powder 3.
- Composition D: x 3.5% of powder 4.
- Composition E: x 3.5% of powder 5.
- Composition F: x 3.5% powder 6.
- compositions G to L and Control 2 of TABLE 2 are compositions of oil-in-water emulsion type comprising 10% fat phase which can correspond for example to moisturizing day creams, so-called rich creams.
- the method of preparing the compositions below comprises (1) combining and heating at 75 ° C the aqueous phase A, (2) combining and heating at 75 ° C the fat phase B, (3) adding the fat phase B to phase A slowly while stirring vigorously to form an emulsion and then (4) cool to room temperature before adding the constituents of phase C with stirring and then the powder (phase D) (except for the control) with stirring slowly.
- Composition J: x 3.5% powder 4.
- COPA powder substantially increases the consistency of the cream and allows it to give an impression of richness to the user, without increasing the compounds oily, which could lead to a greasy feeling
- CoPA powders containing more than 20 mol% of PA 12 give a softer feel and a more pronounced powdery appearance.
- compositions M to N and Control 3 of TABLE 3 are compositions comprising oil-in-water emulsion type comprising 15.5% fat phase. These compositions correspond, for example, to anti-wrinkle cream formulations,
- the smoothing effect of the composition N was measured by the fringe projection method, the principle of which is as follows: the measurement of the cutaneous relief by projection of fringes is carried out at the level of a crow's foot for 20 healthy female subjects.
- fringe projections makes it possible to objectify changes in the cutaneous topography of the crow's feet.
- the measurements are made by means of an optical system dedicated to the metrology of the surface relief.
- This system includes a sensor associated with a projector and a high resolution CCD camera.
- the average axial and lateral resolutions are of the order of 10 ⁇ m.
- the analysis of the surface cutaneous topography is performed by calculating the standard parameters of roughness. These parameters are extracted from a surface of 30x40 mm (12 5 cm 2 ), expressed in mm. The quantified parameters are on a series of profiles perpendicular to the lines and wrinkles of the region of interest.
- the parameter SPt (Maximum amplitude of relief) is extracted.
- the decrease of SPt signifies an attenuation of the main ride.
- Formulation N led to a reduction of SPt parameters of 4% after application of the product to the crow's feet area and 6% after 2 hours.
- compositions O to P and Control 4 of TABLE 4 are oil-in-water emulsion type compositions comprising 26.5% fat phase. These compositions correspond, for example, to sun protection cream formulations with a high degree of protection.
- the process for preparing the compositions below consists of (1) combining and heating at 70 ° C. the aqueous phase A, (2) combining and heating at 70 ° C. the fatty phase B, (3) adding the fatty phase B to phase A slowly while stirring vigorously to form an emulsifier and then (4) cool to room temperature before adding the constituents of phase C, then (5) phase D with stirring, then (6) the powder (phase E) (except for the control) with gentle shaking.
- Composition O: x 5% powder 1.
- Composition P: x 5% powder 2.
- the copolyamides provide a smoothness and a powdery residue much higher than pure polyamide 12 powders; they decrease more significantly the whitening effect of sunscreens.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0754431A FR2914856B1 (en) | 2007-04-12 | 2007-04-12 | COSMETIC COMPOSITION COMPRISING A FINE POWDER |
PCT/FR2008/050662 WO2008145889A2 (en) | 2007-04-12 | 2008-04-14 | Cosmetic composition comprising a fine powder |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2134313A2 true EP2134313A2 (en) | 2009-12-23 |
Family
ID=38752554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08788180A Withdrawn EP2134313A2 (en) | 2007-04-12 | 2008-04-14 | Cosmetic composition comprising a fine powder |
Country Status (11)
Country | Link |
---|---|
US (1) | US10463889B2 (en) |
EP (1) | EP2134313A2 (en) |
JP (1) | JP5551580B2 (en) |
KR (1) | KR101516444B1 (en) |
CN (1) | CN101677915B (en) |
AU (1) | AU2008257296A1 (en) |
BR (1) | BRPI0810537B1 (en) |
FR (1) | FR2914856B1 (en) |
MX (1) | MX336952B (en) |
RU (1) | RU2009141710A (en) |
WO (1) | WO2008145889A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008051007A1 (en) * | 2008-10-13 | 2010-04-15 | Beiersdorf Ag | Polyamide-5 compounds in cosmetic preparations |
FR2962042B1 (en) | 2010-07-01 | 2013-02-08 | Arkema France | COSMETIC COMPOSITION COMPRISING COPA. |
NZ615623A (en) | 2011-03-02 | 2015-06-26 | Pibed Ltd | Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols |
FR2979235B1 (en) * | 2011-08-26 | 2015-04-03 | Lvmh Rech | MASCARA IN THE FORM OF POWDER |
KR101584410B1 (en) * | 2013-12-04 | 2016-01-13 | 지에스칼텍스 주식회사 | Nylon blend composition having improved heat resistance and impact strength and method for preparing the same |
FR3019040B1 (en) * | 2014-03-31 | 2016-03-11 | Arkema France | COSMETIC COMPOSITION FOR SKIN LIGHTENING |
WO2017217660A1 (en) * | 2016-06-13 | 2017-12-21 | 연세대학교 산학협력단 | Composition containing suberic acid or salt thereof as active ingredient, and having effects of improving skin moisturization, skin exfoliation, enhancing skin elasticity, inhibiting erythema, alleviating skin wrinkles, or alleviating skin photoaging |
KR102360818B1 (en) * | 2017-06-30 | 2022-02-09 | (주)아모레퍼시픽 | Water Dispersion Liquid Cosmetic Composition for Eye-makeup |
KR20190037454A (en) * | 2017-09-29 | 2019-04-08 | (주)아모레퍼시픽 | Priming cosmetic composition and manufacturing method of the same |
CN110974715B (en) * | 2019-12-26 | 2023-08-01 | 常州纳欧新材料科技有限公司 | APG modified MBBT composite material and preparation method of aqueous slurry thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1661546A1 (en) * | 2004-11-30 | 2006-05-31 | Arkema | Cosmetic composition comprising a fine and porous powder |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2478465A1 (en) * | 1980-03-18 | 1981-09-25 | Oreal | NEW COSMETIC COMPOSITIONS FOR HAIR, IN TWO LIQUID PHASES, AND THEIR APPLICATION |
US4610919A (en) * | 1985-06-14 | 1986-09-09 | Fiber Bond Corporation | Binder for fibrous padding |
US5874091A (en) * | 1990-09-27 | 1999-02-23 | L'oreal | Cosmetic composition comprising a dispersion of lipid vesicles as well as melanin pigments |
JP4089852B2 (en) * | 1999-03-01 | 2008-05-28 | 住化エンビロサイエンス株式会社 | Production method of coarse copolymer polyamide fine particles |
FR2811669A1 (en) | 2000-07-11 | 2002-01-18 | Atofina | PROCESS FOR THE PREPARATION OF POROUS POWDERS OF COPOLYESTERAMIDES AND POWDERS THUS OBTAINED |
JP2007500749A (en) * | 2003-06-09 | 2007-01-18 | カラー アクセス,インコーポレイティド | Stable cosmetic emulsion containing polyamide |
EP1676556B1 (en) * | 2004-10-22 | 2012-01-11 | L'Oréal | Cosmetic composition containing a polyorganosiloxane polymer |
DE102004058073A1 (en) | 2004-12-01 | 2006-06-08 | Basf Ag | Process for the preparation of an aqueous polyamide dispersion |
WO2006126563A1 (en) * | 2005-05-25 | 2006-11-30 | Toray Industries, Inc. | Polyamide resin fine particles and process for production thereof |
JP4951893B2 (en) * | 2005-08-23 | 2012-06-13 | 東レ株式会社 | Polycaproamide resin fine particles and cosmetics containing the same |
FR2903595B1 (en) * | 2006-07-11 | 2008-08-22 | Rhodia Recherches & Tech | COSMETIC COMPOSITIONS COMPRISING A THERMOPLASTIC MATERIAL POWDER |
-
2007
- 2007-04-12 FR FR0754431A patent/FR2914856B1/en active Active
-
2008
- 2008-04-14 WO PCT/FR2008/050662 patent/WO2008145889A2/en active Application Filing
- 2008-04-14 RU RU2009141710/15A patent/RU2009141710A/en not_active Application Discontinuation
- 2008-04-14 CN CN200880019907.5A patent/CN101677915B/en active Active
- 2008-04-14 JP JP2010502556A patent/JP5551580B2/en active Active
- 2008-04-14 EP EP08788180A patent/EP2134313A2/en not_active Withdrawn
- 2008-04-14 KR KR1020097023323A patent/KR101516444B1/en active IP Right Grant
- 2008-04-14 BR BRPI0810537-5A patent/BRPI0810537B1/en active IP Right Grant
- 2008-04-14 MX MX2009011000A patent/MX336952B/en active IP Right Grant
- 2008-04-14 US US12/595,672 patent/US10463889B2/en active Active
- 2008-04-14 AU AU2008257296A patent/AU2008257296A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1661546A1 (en) * | 2004-11-30 | 2006-05-31 | Arkema | Cosmetic composition comprising a fine and porous powder |
Also Published As
Publication number | Publication date |
---|---|
CN101677915A (en) | 2010-03-24 |
WO2008145889A3 (en) | 2009-02-19 |
BRPI0810537B1 (en) | 2021-03-02 |
KR101516444B1 (en) | 2015-05-07 |
WO2008145889A2 (en) | 2008-12-04 |
BRPI0810537A2 (en) | 2020-08-18 |
JP2010523631A (en) | 2010-07-15 |
CN101677915B (en) | 2015-05-20 |
US20100215701A1 (en) | 2010-08-26 |
MX2009011000A (en) | 2009-12-11 |
RU2009141710A (en) | 2011-05-20 |
US10463889B2 (en) | 2019-11-05 |
FR2914856A1 (en) | 2008-10-17 |
FR2914856B1 (en) | 2012-08-03 |
KR20100016340A (en) | 2010-02-12 |
JP5551580B2 (en) | 2014-07-16 |
MX336952B (en) | 2016-02-03 |
AU2008257296A1 (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2134313A2 (en) | Cosmetic composition comprising a fine powder | |
CA2526279C (en) | Cosmetic composition comprising a fine, porous powder | |
EP0908175B1 (en) | Stable topical composition containing a solid elastomeric organopolysiloxane and spherical particles | |
EP1870076A2 (en) | Solid emulsion with liquid oil phase structured by a polymer | |
EP2421494B1 (en) | Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent | |
FR3073411A1 (en) | COMPOSITION COMPRISING A FATTY PHASE, A LIPOPHILIC POLYMER AND A VOLATILE HYDROCARBON OIL | |
FR2757396A1 (en) | CARE COMPOSITION CONTAINING ORGANOPOLYSILOXANE GEL | |
FR2908982A1 (en) | Cosmetic composition for making up and caring for skin, lips and keratin fibres, comprises one or more aprotic hydrocarbon-based volatile solvent comprising not more than one branch, in physiologically acceptable medium | |
EP1925292A1 (en) | Cosmetic composition comprising at least one volatile carbonic acid ester | |
EP1925291B1 (en) | Cosmetic composition comprising at least one volatile ester | |
WO2009092934A1 (en) | Cosmetic composition, in particular makeup composition for keratinic materials, having improved cosmetic properties | |
FR2892019A1 (en) | Caring for wrinkled skin comprises applying composition including pulverulent phase comprising porous particles which comprise antiwrinkle active principle; and applying composition including fatty and/or aqueous phase comprising solvent | |
EP1516610B1 (en) | Cosmetic composition containing colloidal particles as inorganic filler | |
FR2964562A1 (en) | Cosmetic product, useful in cosmetic process for caring keratin materials, comprises a composition comprising aqueous phase and fatty phase, and composition comprising a mixture of organopolysiloxane elastomer and silicone oil | |
FR3006177A1 (en) | COSMETIC USE AS A DEODORANT ACTIVE OF A SILICY MATERIAL OBTAINED BY HYDROLYSIS AND CONDENSATION OF A TETRAALCOXYSILANE AND AN AMINOALKYL TRIALCOXYSILANE | |
AU2012202501B2 (en) | Cosmetic composition comprising a fine powder | |
FR2952528A1 (en) | MIXTURE OF SOLVENTS HYDROCARBONES. | |
FR2898049A1 (en) | Cosmetic process, useful for lip care or make-up e.g. to moisturize the lips, comprises topical application of a composition containing an oil emulsion of cyclic lipopeptide e.g. surfactin in a polar phase e.g. water-polyol mixture | |
FR2954106A1 (en) | COLORED COMPOSITION FOR CAMOUFLING SKIN IMPERFECTIONS | |
WO2020128392A1 (en) | Anhydrous cosmetic composition comprising a polysilsesquioxane film-forming resin | |
FR2954105A1 (en) | Cosmetic composition in the form of oil-in-water emulsion, useful e.g. as foundation, comprises volatile linear alkane and powder colorant material treated in surface with lipophilic or hydrophobic treatment agent, in a medium | |
FR2915894A1 (en) | Composition in oil-in-water emulsion form, useful for make-up and/or care of keratinous material, comprises an internal fatty phase and external aqueous phase comprising an inulin modified by hydrophobic chain | |
FR3042707A1 (en) | AQUEOUS COMPOSITION COMPRISING AN ORGANOSILANE OR OLIGOMER OF THE SAME ORGANOSILANE AND A HYDROPHOBIC COATED PIGMENT | |
FR2997843A1 (en) | Cosmetic composition of water-in-silicone emulsion type, useful as make-up product for caring keratinous material i.e. dark skin, comprises oily phase and ferric blue pigment surface treated with hydrophobic or lipophilic curing agent | |
FR2873580A1 (en) | Cosmetic composition, useful for e.g. make-up or non-therapeutic treatment of keratinous fibers, comprises cyclic volatile silicon oil and linear volatile alkyltrisiloxane oil in a medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091008 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20120810 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APBV | Interlocutory revision of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNIRAPE |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 19/00 20060101ALI20190327BHEP Ipc: A61K 8/88 20060101AFI20190327BHEP |
|
INTG | Intention to grant announced |
Effective date: 20190425 |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
INTC | Intention to grant announced (deleted) | ||
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20231101 |